YERVOY SINJ 200MG 40ML 1VLX
Condition : New
0
From UAE
To United States
in 5-10 days
Description
Yervoy (ipilimumab) is a monoclonal antibody used for the treatment of several cancers, including melanoma, renal cell carcinoma, and non-small cell lung cancer. It works by targeting CTLA-4, a protein receptor that downregulates the immune system. By inhibiting CTLA-4, Yervoy enhances the immune system’s ability to fight cancer cells. It is administered as an intravenous infusion, typically once every 3 to 6 weeks.
Pros:
- Improved Survival Rates: Yervoy has been shown to improve survival rates in patients with advanced melanoma and other cancers.
- Immunotherapy Benefits: Unlike traditional chemotherapy, it harnesses the body’s immune system to specifically target cancer cells, potentially reducing damage to healthy cells.
- Combination Therapy: Often used in combination with other drugs like nivolumab (Opdivo), which can enhance the overall effectiveness of the treatment.
- Severe Side Effects: Yervoy can cause serious and sometimes fatal immune-mediated side effects, such as colitis, hepatitis, endocrinopathies, and skin reactions. Continuous monitoring is necessary to manage these risks.
- High Cost: A single 200 mg/40 mL vial of Yervoy can cost around $9,012.81 to $9,285.07 in the United States, making it a very expensive treatment option.
- Frequent Monitoring and Hospital Visits: Patients require regular check-ups to monitor for side effects, which can be time-consuming and burdensome.
- US Prices: Approximately $9,012.81 to $9,285.07 per 200 mg/40 mL vial. Prices can vary depending on the pharmacy and location .
- Patient Assistance Programs: Financial assistance is available through programs like the BMS Oncology Co-Pay Assistance Program, which can significantly reduce out-of-pocket costs for eligible patients .